A Single-Dose Study of MK-8351 in a Lung Allergen Challenge (MK-8351-003)

NCT01926002 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Low-Dose MK-8351
DRUG: High-Dose MK-8351
DRUG: Placebo to MK-8351

Sponsor

Merck Sharp & Dohme LLC